• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Biogen CEO's 2021 pay remains level despite Aduhelm tribulations | Fierce Pharma





Ok people let’s do the math on this one.
Michel gets paid all of that money, BIIB only sells $300k in 2nd qrt 2021 of Adu then lays people off, paying severances and then rehires useless managers and gives them 10% raises and astronomical sign-ons.

Anyone else think that the BOARD has lost their minds to allow HR and SLT to do this?